Clinical Trial Update: LIPS-B: Lung Injury Prevention Study With Budesonide and Beta [Phase 2]

View source ↗

Summary

Phase 2 outcome of the LIPS-B study evaluating budesonide with a beta-adrenergic approach for preventing lung injury in patients at risk for Acute Respiratory D…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Budesonide (BUDESONIDE)
• beta-adrenergic agonist (beta-adrenergic agonist)

Snippet

Sponsor: Mayo Clinic | Conditions: Acute Respiratory Distress Syndrome (ARDS) | Phase 2 | Status: COMPLETED | Results posted: 2016-09-05